Objective: Fluorescence molecular tomography (FMT) can provide valuable molecular information by mapping the bio-distribution of fluorescent reporter molecules in the intact organism. Various prototype FMT systems have been introduced during the past decade. However, none of them has evolved as a standard tool for routine biomedical research. The goal of this paper is to develop a software package that can automate the complete FMT reconstruction procedure.

Methods: We present smart toolkit for fluorescence tomography (STIFT), a comprehensive platform comprising three major protocols: 1) virtual FMT, i.e., forward modeling and reconstruction of simulated data; 2) control of actual FMT data acquisition; and 3) reconstruction of experimental FMT data.

Results: Both simulation and phantom experiments have shown robust reconstruction results for homogeneous and heterogeneous tissue-mimicking phantoms containing fluorescent inclusions.

Conclusion: STIFT can be used for optimization of FMT experiments, in particular for optimizing illumination patterns.

Significance: This paper facilitates FMT experiments by bridging the gaps between simulation, actual experiments, and data reconstruction.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TBME.2019.2907460DOI Listing

Publication Analysis

Top Keywords

smart toolkit
8
toolkit fluorescence
8
fluorescence tomography
8
fmt
8
fmt experiments
8
reconstruction
6
tomography simulation
4
simulation reconstruction
4
reconstruction validation
4
validation objective
4

Similar Publications

Non-Small Cell Lung Cancer (NSCLC) is a formidable global health challenge, responsible for the majority of cancer-related deaths worldwide. The Platelet-Derived Growth Factor Receptor (PDGFR) has emerged as a promising therapeutic target in NSCLC, given its crucial involvement in cell growth, proliferation, angiogenesis, and tumor progression. Among PDGFR inhibitors, avapritinib has garnered attention due to its selective activity against mutant forms of PDGFR, particularly PDGFRA D842V and KIT exon 17 D816V, linked to resistance against conventional tyrosine kinase inhibitors.

View Article and Find Full Text PDF
Article Synopsis
  • There is a growing need for intelligent medical image computing algorithms and platforms in clinical research, but current platforms lack adequate support for AI and clinical applications.
  • The SenseCare research platform has been developed to enhance translational research in intelligent diagnosis and treatment planning, featuring advanced 3D visualization, web-based access, fast data synchronization, and high security.
  • SenseCare offers various AI toolkits for tasks like image segmentation and lesion detection, aiding clinical researchers in developing customized AI models for applications in diagnosing diseases such as lung cancer and coronary artery disease.
View Article and Find Full Text PDF

Background: Phenotypic data comparison is essential for disease association studies, patient stratification, and genotype-phenotype correlation analysis. To support these efforts, the Global Alliance for Genomics and Health (GA4GH) established Phenopackets v2 and Beacon v2 standards for storing, sharing, and discovering genomic and phenotypic data. These standards provide a consistent framework for organizing biological data, simplifying their transformation into computer-friendly formats.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the impact of smart home technologies on older adults' quality of life and well-being as they age in place.
  • Over a year, researchers conducted a trial comparing traditional care with home monitoring through a smart system, analyzing various quality of life and depression metrics at 6 and 12 months.
  • Results showed a temporary improvement in the intervention group's quality of life at 6 months, but this effect diminished by the 12-month mark, indicating the need for ongoing evaluation of such technologies.
View Article and Find Full Text PDF

Feasibility Randomized Controlled Trial of the Toolkit for Optimal Recovery After Concussion: A Live Video Program to Prevent Persistent Concussion Symptoms in Young Adults With Anxiety.

Arch Phys Med Rehabil

November 2024

Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Department of Psychiatry, Boston, Massachusetts.

Article Synopsis
  • The study aimed to evaluate the Toolkit for Optimal Recovery after Concussion (TOR-C) and its effectiveness in preventing continuous concussion symptoms in young adults with anxiety compared to an active control group (HE-C).
  • A total of 50 participants aged 18-35, who had suffered a concussion within the last 3-10 weeks and displayed anxiety, engaged in four 45-minute Zoom sessions focused on different interventions.
  • Results showed that both intervention groups met feasibility benchmarks and experienced notable improvements in various outcomes like concussion symptoms and anxiety levels, with the TOR-C group specifically showing greater progress in certain areas like mindfulness and all-or-nothing behavior.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!